Molecular classification of cutaneous malignant melanoma by gene expression profiling

Nature - Tập 406 Số 6795 - Trang 536-540 - 2000
Michael Bittner1,2,3, P.S. Meltzer1,2,3, Yaning Chen1,2,3, Yuan Jiang1,2,3, Elisabeth A. Seftor4, Mary J.C. Hendrix4, Michael D. Radmacher5,6, Richard H. Simon5,6, Zohar Yakhini7, Amir Ben‐Dor8, Nick Sampas7, Edward R. Dougherty9,10, E. Wang7, Francesco M. Marincola1,2,3, Chris Gooden1,2,3, John Lueders1,2,3, Arthur A. Glatfelter1,2,3, Pamela M. Pollock7, John D. Carpten1,2,3, Immaculata De Vivo1,2,3, D. Leja1,2,3, Kathleen Dietrich1,2,3, Christian Beaudry7, Michael E. Berens7, David S. Alberts4,5,6, Vernon K. Sondak4,5,6, Nicholas K. Hayward7, Jeffrey M. Trent1,2,3
1Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892, USA
2Queensland Institute of Medical Research, Herston, Queensland 4029, Australia ²² Neuro-Oncology Laboratory, Barrow Neurological Institute, Phoenix, Arizona 85013-4496, USA
3Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724, USA
4Department of Anatomy and Cell Biology, University of Iowa Cancer Center, Iowa City, Iowa 52242-1109, USA
5Department of Surgery, University of Michigan, Ann Arbor, Michigan 48109 USA
6National Cancer Institute, DCTDC, NIH, Bethesda, Maryland 20852, USA
7 Chemical and Biological Systems Department, Agilent Laboratories, 3500 Deer Creek Road, Palo Alto, California 94304, USA
8Computer Science and Engineering Department, University of Washington, Seattle, Washington 98105, USA
9Department of Electrical Engineering, Texas A&M University, College Station, Texas 77843 USA
10I National Cancer Institute, Surgery Branch, NIH, Bethesda, Maryland 20850, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hall, H. I., Miller, D. R., Rogers, J. D. & Bewerse, B. Update on the incidence and mortality from melanoma in the United States. J. Am. Acad. Dermatol. 40, 35– 42 (1999).

Weyers, W., Euler, M., Diaz-Cascajo, C., Schill, W. B. & Bonczkowitz, M. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer 86, 288– 299 (1999).

Byers, H. R. & Bhawan, J. Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma. Hematol. Oncol. Clin. North Am. 12, 717–735 ( 1998).

McMasters, K. M., Sondak, V. K., Lotze, M. T. & Ross, M. I. Recent advances in melanoma staging and therapy. Ann. Surg. Oncol. 6, 467–475, ( 1999).

Maniotis, A. J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155, 739–752 ( 1999).

DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457– 460 (1996).

Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009– 5013 (1998)

Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212–9217 (1999).

Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 , 531–537, (1999).

Alizadeh, A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).

Bittner, M., Meltzer P. & Trent J. Data analysis and integration: of steps and arrows. Nature Genet. 22, 213– 215 (1999).

Eisen, M. B., Spellman, P. T., Brown P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863–14868 (1998).

Everitt, B. Applied Multivariate Data Analysis. (Oxford Univ. Press, New York, 1992)

Ben-Dor, A., Shamir, R. & Yakhini, Z. Clustering gene expression patterns. J. Comput. Biol. 6, 281–297 ( 1999).

Adams, J. C. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. Mol. Biol. Cell 8, 2345 –2363 (1997).

Scott, G. & Liang, H. pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Exp. Cell Res. 219, 197–203 (1995).

Jannji, B., Melchior, C., Guon, V., Vallar, L. & Kieffer, N. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-llinked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int. J. Cancer 83, 255–262 (1999).

Hieken, T. et al. Beta1 integrin expression in malignant melanoma predicts occult lymph note metastases. Surgery 118, 669– 673 (1995).

Van Belle, P. et al. Progression-related expression of beta3 integrin in melanomas and nevi. Hum. Pathol. 30, 562– 567 (1999)

Woods, A., Longley, R., Tumova, S. & Couchman, J. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 374 , 66–72 (2000).

Helige, C. et al. Interrelation of motility, cytoskeletal organization and gap junctional communication with invasiveness of melanocytic cells in vitro . Invasion Metastasis 17, 26– 41 (1997).

Maung, K., Easty, DJ., Hill, S. & Bennett, D. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 18, 6824–6828 (1999).

Silletti, S., Paku, S. & Raz, A. Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization. Int. J. Cancer 76, 120– 128 (1998)

Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P. & Trent, J. Expression profiling using cDNA microarrays. Nature Genet. 21, 10–14, (1999).

Khan, J., Bittner, M., Chen, Y., Meltzer, P. & Trent, J. DNA Microarray technology: the anticipated impact on the study of human disease. Biochim. Biophys. Acta 1423, 17–28 (1999).

Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614 –1617 (1998).

Berens, M., Rief, M., Loo, M. & Giese, A. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin. Exp. Metastasis 12, 405 –415 (1994).

Giese, A., Loo, M., Norman, S., Treasurywala, S. & Berens, M. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J. Cell Sci. 109, 2161–8 (1996).

Hendrix, M., Seftor, E., Seftor, R. & Fidler, I. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett. 38, 137– 147 (1987).

Hendrix, M., Seftor, E., Chu, Y., Trevor, K. & Seftor, R. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507–525 (1996).